Skip to content

The Archive · A Source

S&E bio Secures Landmark Approval for First Exosome-Based Stroke Therapy Trial in Korea

MedPath Trial News 2024 trial.medpath.com/news/2eab5d784ed191ab/s-e-bio-secures-landmark-approval-for-first-exosome-based-stroke-therapy-trial-in-korea